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Introduction
HIV transmission occurs predominantly across mucosal
surfaces. An ideal preventive strategy would be to target
HIV at mucosal entry sites to prevent infection. We
developed a novel epithelial stem cells-based AIDS pre-
ventive approach in female macaques. This approach is
based on the ability of therapeutic lentiviral vectors inte-
grated in mucosal epithelial stem cells to induce virus-
specific cellular immune responses at mucosal sites of
viral entry. We first intended to expose the cervicovaginal
tract to conditions used for intravaginal vaccine delivery
and non-invasively image local tissues to determine the
vaccination effects on epithelial integrity and generation
of antigen-specific mucosal immune responses.
Methods
Experimental cervicovaginal vaccinations were carried out
on 12 uninfected female macaques, in conjunction with
deliberate abrasion of epithelium using Depo-Provera, 4%
nonoxynol-9 treatments, or gentle abrasions to reduce
vaginal epithelial height and cell layers number. Longitudi-
nal study was performed for baseline levels of hormones,
antibodies, cytokine profiles during normal cycling with/
without vaccination. Endoscopic colposcopy followed by
optical coherence tomography (OCT) helped monitor
macaque cervical-vaginal epithelium pre-, post-, without
treatment to measure epithelial thickness changes. Colpo-
scopy help visualizing the vagina and cervix. Blood sam-
ples and biopsies were collected at various time-points to
evaluate immune responses to vaccination.
Results
OCT imaging provided quantitative measurements of
epithelial changes and detected minute changes in
epithelial thickness and morphology. Colposcopy and
OCT imaging correlated with hormone levels and biop-
sies imaging. Depo-Provera gave better results in epithe-
lium thinning but naturally cycling macaques showed
clearer thickness differences. All collected secretions,
biopsies and blood samples gave a better understanding
of the correlation between menstrual cycle, hormonal
level, epithelial thickness changes. Optimal conditions
for vaccine delivery were determined and revealed virus-
specific T cell response in all vaccinated animals.
Conclusions
OCT is well suited for the examination of superficial
mucosal layers and close underlying stromal structures of
tissues. In this study, we demonstrated the feasibility of
using epithelial stem cells as mucosal antigen-presenting
cells to induce viral specific immune responses at mucosal
sites, and improved our knowledge of the role of mucosal
surfaces.
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